Protective monoclonal antibody compositions for infections due t

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 858, 530387, 530388, 530389, 530808, 530809, 435 7021, 43524026, 43524027, 4352402, 435948, 436548, 935100, 935104, 935107, 935110, A61K 3940, C07K 1528, C12N 510

Patent

active

049700707

ABSTRACT:
Immortalized cell lines have been produced that secrete human monoclonal antibodies capable of binding to bacterial species which are a major cause of neonatal sepsis and meningitis. These antibodies have been found to be protective against lethal challenges of these bacteria, which include group B streptococcus, E. coli, K1, and Neisseria meningitidis group B. Pharmaceutical compositions containing these antibodies, which can be in combination with other monoclonal anitbodies, blood plasma fractions and antimicrobial agents, and the prophylactic and therapeutic use of such compositions in the management of infections, are included.

REFERENCES:
patent: 4464465 (1984-08-01), Lostroum
patent: 4587121 (1986-05-01), Collins et al.
patent: 4675287 (1987-06-01), Reisfeld et al.
patent: 4677070 (1987-06-01), Larrick et al.
patent: 4734279 (1988-03-01), Stephan et al.
Ruch, F. E., Jr., "Monoclonal Autibody to Streptococcal Group B Carbohydrate: Applications in Latex Agglutination and Immunoprecipitin Assays", J. Clin Microbiol., 16(1): 145-152, Jul. 1982.
Shigeoka, A. O. et al. "Protective Efficacy of Hybridoma Type-Specific Antibody Against Experimental Infection with Group-B Steptococcus", J. Inf. Dis., 149(3): 363-372, Mar. 1984.
Sorensen, R. U. et al., "Defective Cellular Immunity to Gram-Negative Bacteria in Cystic Fibrosis Patients", Infection and Immunity, 23: 398-402, Feb. 1979.
Moreno, C. et al., "Innunological Properties of Monoclonal Antibodies Specific for Meningococcal Polysaccharides: The Protective Capacity of IgM Autibodies Specific for Polysaccharide Group B", J. Gen. Microbiol., 129: 2451-2456, 1983.
Hienaux, J. R. et al., "Study of the Idiotypy of Lipopoly-Saccharide-Specific Polyclonal and Monoclonal Antibodies", Eur. J. Immunol., 12:797-803, 1982.
Pluschke, G. et al., "Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis and Monoclonal Antibodies as Tools for the Subgrouping of Escherichia Coli Lipopolysaccharide 018 and 023 Antigens", Infection and Immunity, 51(1):286-293, Jan. 1986.
Raff, Howard V., "Human Monoclonal Antibodies to Group B Streptococcus-Reactivity and In Vivo Protection Against Multiple Serotypes", J. Exp. Med., vol. 168, pp. 905-917, Sep. 1988.
Baker (1986), N. Engl. J. Med., 314:1702-1704.
Backer et al. (1976), N. Engl. J. Med., 294:753-756.
Kaijser et al. (1972), Scand. J. Immunol., 1:27-32
Kaijser et al. (1977), Infect. Immun., 17:286-289.
Egan et al. (1983), J. Exp. Med., 158:1006-1011.
Yoder et al. (1986), Pediatr. Clin. N. Amer., 33:481-501.
Lancefield et al. (1975), J. Exp. Med., 142:165-179.
Christensen et al. (1984), Eur. J. Pediatr., 142:86-88.
Gotoff et al. (1986), J. Infect. Dis., 153:511-519.
Anthony et al. (1985), J. Infect. Dis., 151:221-226.
Collins et al. (1984), Am. J. Med., 76:155.
Teng et al. (1985), Proc. Natl. Acad. Sci. USA, 82:1790.
Hornberger et al. (1985), Fed. Am. Soc. Exp. Biol. 69th Annual Meeting, Abs. No. 5366.
Cryz et al. (1984), Infect. Immun., 45:139.
Gigliotti et al. (1984), J. Infect. Dis., 149:43.
Givner et al. (1985), J. Infect. Dis., 151:217.
Ruch, Jr. et al. (1982), J. Clin. Microbiol., 16:145.
Baltimore et al. (1979), J. Infect. Dis., 140:81.
Shigeoka et al. (1984), J. Infect. Dis., 150:63-70.
Hemming et al. (1987), J. Infect. Dis., 156:655-658.
Harper et al. (1986), Rev. Infect. Dis., 8:S401-S408.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Protective monoclonal antibody compositions for infections due t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protective monoclonal antibody compositions for infections due t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protective monoclonal antibody compositions for infections due t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-775948

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.